semaglutide dose vs tirzepatide dose and Dosage Charts: A Complete Guide tirzepatide semaglutide dose conversion and

Patients who discontinued tirzepatide after 36 weeks of weight loss regained approximately half of their lost weight over the following year, while those who continued treatment maintained their results

Common adverse effects of Wegovy include: Gastrointestinal symptoms nausea, vomiting, diarrhoea, and constipation (affecting 2050% of users, particularly during dose escalation) Dehydration risk secondary to gastrointestinal effects Dizziness and fatigue especially when combined with caloric restriction Hypoglycaemia primarily a risk when combined with insulin or sulfonylurea therapy

Most of the eligibility criteria above are more concerned with your overall blood sugar management and if you're on medications (and what those medications are)

However, it's unsuitable for individuals with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

The weight loss drug also positively impacts symptoms, physical limitations, and body weight in HFpEF patients

These combined effects make oral semaglutide a potent tool for reaching sustainable weight loss goals